SC
Savant Capital Portfolio holdings
AUM
$16.1B
1-Year Return
14.38%
This Quarter Return
+8.8%
1 Year Return
+14.38%
3 Year Return
+48.07%
5 Year Return
+73.78%
10 Year Return
+154.4%
AUM
$16.1B
AUM Growth
+$2.32B
(+17%)
Cap. Flow
+$1.24B
Cap. Flow
% of AUM
7.67%
Top 10 Holdings %
Top 10 Hldgs %
39.16%
Holding
1,981
New
393
Increased
869
Reduced
537
Closed
138
Top Buys
| 1 |
Dimensional US Large Cap Value ETF
DFLV
|
+$115M |
| 2 |
Vanguard Growth ETF
VUG
|
+$88.4M |
| 3 |
Dimensional International High Profitability ETF
DIHP
|
+$87.8M |
| 4 |
Dimensional US Small Cap Value ETF
DFSV
|
+$70.4M |
| 5 |
Vanguard Total Bond Market
BND
|
+$64.8M |
Top Sells
| 1 |
Dimensional US Marketwide Value ETF
DFUV
|
+$24.4M |
| 2 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$15M |
| 3 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$12.6M |
| 4 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$11.1M |
| 5 |
SW
Smurfit Westrock plc
SW
|
+$9.82M |
Sector Composition
| 1 | Technology | 6.06% |
| 2 | Financials | 3.47% |
| 3 | Industrials | 3% |
| 4 | Consumer Discretionary | 2.46% |
| 5 | Healthcare | 2.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Repay Holdings
RPAY
$509M
| $132K | ﹤0.01% |
+27,451
| New | +$132K |
|
1702
Genworth Financial
GNW
$3.53B
| $132K | ﹤0.01% |
16,909
+592
| +4% | +$4.61K |
|
1703
Udemy
UDMY
$1.02B
| $130K | ﹤0.01% |
+18,535
| New | +$130K |
|
1704
Syndax Pharmaceuticals
SNDX
$1.37B
| $130K | ﹤0.01% |
13,882
-12,956
| -48% | -$121K |
|
|
CGAU
1705
Centerra Gold
CGAU
$1.8B
| $130K | ﹤0.01% |
+18,021
| New | +$130K |
|
1706
Metals Acquisition
MTAL
$1.01B
| $129K | ﹤0.01% |
+10,692
| New | +$129K |
|
1707
Heartland Express
HTLD
$673M
| $128K | ﹤0.01% |
+14,870
| New | +$128K |
|
1708
Zegna
ZGN
$2.29B
| $128K | ﹤0.01% |
14,957
+3,961
| +36% | +$33.9K |
|
1709
Hafnia
HAFN
$3.08B
| $128K | ﹤0.01% |
+25,605
| New | +$128K |
|
1710
TransAlta
TAC
$3.65B
| $127K | ﹤0.01% |
+11,745
| New | +$127K |
|
1711
Granite Ridge Resources
GRNT
$689M
| $126K | ﹤0.01% |
+19,742
| New | +$126K |
|
1712
Open Lending Corp
LPRO
$252M
| $126K | ﹤0.01% |
+64,771
| New | +$126K |
|
1713
Xeris Biopharma Holdings
XERS
$1.24B
| $125K | ﹤0.01% |
26,839
+466
| +2% | +$2.18K |
|
1714
NeoGenomics
NEO
$1.02B
| $125K | ﹤0.01% |
+17,101
| New | +$125K |
|
1715
Kearny Financial
KRNY
$414M
| $124K | ﹤0.01% |
19,208
-14,663
| -43% | -$94.7K |
|
1716
ICL Group
ICL
$7.87B
| $123K | ﹤0.01% |
17,979
+5,952
| +49% | +$40.8K |
|
|
DX
1717
Dynex Capital
DX
$1.68B
| $123K | ﹤0.01% |
+10,088
| New | +$123K |
|
1718
Santander
BSBR
$40.1B
| $123K | ﹤0.01% |
+22,507
| New | +$123K |
|
1719
Humacyte
HUMA
$238M
| $122K | ﹤0.01% |
+58,201
| New | +$122K |
|
1720
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.6B
| $120K | ﹤0.01% |
10,020
+10
| +0.1% | +$119 |
|
1721
Lexeo Therapeutics
LXEO
$284M
| $119K | ﹤0.01% |
+29,667
| New | +$119K |
|
1722
SITE Centers
SITC
$476M
| $119K | ﹤0.01% |
+10,538
| New | +$119K |
|
1723
Green Plains
GPRE
$662M
| $119K | ﹤0.01% |
+19,696
| New | +$119K |
|
1724
Mativ Holdings
MATV
$680M
| $118K | ﹤0.01% |
+17,259
| New | +$118K |
|
|
AHH
1725
Armada Hoffler Properties
AHH
$587M
| $117K | ﹤0.01% |
+16,998
| New | +$117K |
|